News from delmar pharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 03, 2013, 08:00 ET

DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference

 DelMar Pharmaceuticals, Inc., (OTCQB: DMPI), developer of advanced cancer therapeutics, will be featured as a presenting company at the 15th...

Jun 10, 2013, 07:00 ET

DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) today announced that their June 6th RetailInvestorConferences.com presentation is now available for...

Jun 03, 2013, 08:00 ET

DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") announced that the company presented a poster entitled "Phase I/II Study of VAL-083...

May 31, 2013, 07:00 ET

DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com June 6th

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) today announced that Jeffrey Bacha, B.Sc., MBA, President & CEO, will present at...

May 28, 2013, 08:00 ET

DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the company would present an abstract entitled "Phase I/II Study of...

May 16, 2013, 08:37 ET

DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma") is pleased to provide the following update from President & CEO, Mr. Jeffrey...

Apr 10, 2013, 08:00 ET

DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) today announced additional positive interim data from an ongoing Phase I/II clinical trial of...

Apr 01, 2013, 09:27 ET

DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the company would present an abstract entitled "A Phase I/II study...

Mar 13, 2013, 08:00 ET

DelMar Pharma Named to Rocket Builders' 2013"Ready to Rocket" List

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the Company has been named to Rocket Builder's 11th annual "Ready...

Mar 11, 2013, 08:00 ET

DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar"), a clinical and commercial stage drug development company with a focus on the treatment...

Mar 07, 2013, 08:00 ET

DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant

 DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the completion of a $10.5 million private placement. Charles Vista, LLC...

Feb 28, 2013, 13:21 ET

DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") is pleased to announce the appointment of Mr. John K. Bell to the company's Board of...

Feb 25, 2013, 07:00 ET

DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the fourth closing in a private placement consisting of approximately...

Feb 11, 2013, 08:30 ET

DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the third closing in a private placement consisting of approximately 1.2...

Jan 31, 2013, 18:07 ET

Pharmaceuticals Announces $1.5 Million Second Closing in Private Placement

DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced the second closing in a private placement consisting of approximately 1.9...

Jan 25, 2013, 12:50 ET

DelMar Pharmaceuticals Announces Acquisition and $5.4 Million Private Placement to Advance Novel Cancer Therapies

 DelMar Pharmaceuticals, Inc. (OTCQB: BRRY) ("DelMar") today announced the successful acquisition (the "Acquisition"), through a share exchange...